As taken from POZ online Jan. 2015 It is possible to “boost” certain immune cells to enable them to kill HIV-infected reservoir cells that have been awakened from their dormant state, at least in a laboratory setting and in mice. Publishing their findings in the journal Nature, researchers drew immune cells and HIV-infected reservoir CD4 cells from 25 HIV-positive people and then studied those cells in the laboratory and in mice altered to have human immune systems. Read more: http://www.poz.com/articles/boosting_CD8s_761_26716.shtml
Author: webmaster
FDA Approves Early Human Trial of Potential HIV Functional Cure
As taken from POZ on-line 3/2015 The U.S. Food and Drug Administration (FDA) has given the green light to an early human trial of an HIV gene therapy that may lead to a functional cure, Medical Daily reports. The treatment involves drawing blood-producing stem cells from HIV-positive study participants who have had a poor response to antiretroviral (ARV) therapy. Next, the researchers will splice in genetic instructions to immune cells to make them resistant to the virus. Read more: http://www.poz.com/articles/functional_cure_trial_761_26943.shtml
NIH Funds Research Into ‘Kick and Kill’ HIV Cure Strategy
As taken from POZ online edition The National Institutes of Health’s (NIH) Division of AIDS and Infectious Disease Services (DAIDS) has pledged $6.6 million to support the first human clinical trial into a cure strategy known as “kick and kill.” Read more: http://www.poz.com/articles/kick_kill_761_27066.shtml
Improving the effect of HIV drugs by the use of a vaccine
As taken from Medical News Today [MNT] Revised 4/2015 A vaccine containing a protein necessary for virus replication can boost an HIV-infected patient’s immune system, according to clinical research published in the open-access journal Retrovirology. This boost can result in increased effectiveness of antiretroviral drugs. Read more: http://www.medicalnewstoday.com/releases/293191.php
First human study of new HIV antibody therapy shows promise
Article as taken from Medical News Today [MNT] 4/2015 A study trialing a new generation of broadly neutralizing antibodies in humans for the first time has shown promise as a treatment for HIV according to researchers. The results of the clinical trial, published in Nature, have been more successful than previous HIVantibody tests in humans, with the researchers finding that their experimental therapy can reduce the amount of virus present in a patient’s blood significantly. Read more… http://www.medicalnewstoday.com/articles/292175.php
Experimental AIDS Vaccine Targets Hidden Virus
As posted in WebMD 4/29/2015 and as originally presented from HealthDay by Randy Dotinga HIV-infected patients appear to get an immune system boost, study found… Preliminary research suggests that an AIDS vaccine in development can ramp up the body’s immune system, boosting the response to medications HIV-positive patients take. Years of research will be required to confirm that the vaccine works, and researchers don’t yet have the major funding needed to continue and push the experimental vaccine toward the market..Read more at http://www.webmd.com/hiv-aids/news/20150429/experimental-aids-vaccine-targets-hidden-virus
HIV Treatments Work
More than 1.2 million people in the United States are living with HIV. This campaign features people from across the United States who are living with HIV talking about how sticking with care and treatment helps them stay healthy, protect others, and live longer, healthier lives. Read more at http://www.cdc.gov/actagainstaids/campaigns/hivtreatmentworks/index.html
amfAR announces $100 million investment strategy aimed at curing HIV
amfAR, The Foundation for AIDS Research, has announced that it has created a $100 million investment strategy in support of its Countdown to a Cure for AIDS initiative, launched last year with the aim of developing the scientific basis of a cure by 2020. Read more: http://www.medicalnewstoday.com/releases/289786.php Article from Medical News Today
Designer protein ‘blocks all known strains of HIV
From Medical News Today… “Our compound is the broadest and most potent entry inhibitor described so far,” says Michael Farzan, a Scripps Research Institute professor who led the effort.” Read more: http://www.medicalnewstoday.com/articles/289611.php
STOP THE VIRUS
We now know what it takes to help stop the virus. In our bodies. In our communities. It takes all of us. That’s because stopping the virus starts with you. https://www.helpstopthevirus.com/